-
AbbVie used nurse 'ambassadors' to protect Humira sales
fiercepharma
September 19, 2018
In kickbacks case, CA insurance chief says AbbVie used nurse 'ambassadors' to protect Humira sales
-
With EU salivating after Humira biosims, analysts start questioning AbbVie's optimism
fiercepharma
September 17, 2018
Humira biosimilars will hit the European market next month, but AbbVie executives are still soft-pedaling the threat to their top line. CEO Rick Gonzalez and his colleagues say they'll match competitors on price to keep Humira's market-leading position.
-
China accepts first application for Humira biosimilar
biospectrumasia
September 05, 2018
Bio-Thera Solutions is developing several additional proposed biosimilars, including a biosimilar version of Avastin, which is currently being evaluated in a global Phase III clinical trial
-
As Humira competition nears, AbbVie's Imbruvica and Mavyret pick up steam
fiercepharma
July 30, 2018
Even as AbbVie's megablockbuster immunology med Humira inches toward its first biosim competition, the drug is still churning out record sales.
-
AbbVie Announces HUMIRA Patent License with Mylan
biospectrumasia
July 19, 2018
Under the terms of the agreements, AbbVie will grant Mylan a non-exclusive license on specified dates to AbbVie's intellectual property relating to HUMIRA
-
Lilly diabetes drug Trulicity leapfrogs to No. 2 ad spender for June
fiercepharma
July 19, 2018
With six months down in 2018 and six to go, Humira is on track to keep its pharma TV spending crown for 2018.
-
Global Top 10 Best-selling Drugs
W&D
July 05, 2018
This article summarizes and introduces the global top 10 best-selling drugs, to present the readers an impression thereon.
-
AbbVie slammed by FDA for improper handling of Humira death complaints
fiercepharma
June 13, 2018
A number of AbbVie products coming out of its North Chicago, Illinois, manufacturing facility have been tied to death complaints,including its mammoth blockbuster Humira...
-
AbbVie's Humira, Merck's Keytruda and more: The top 10 drugs of 2024
fiercepharma
June 08, 2018
Even as many things change in the drug industry, at least one fact should stay the same in the coming years, according to analysts at EvaluatePharma.
-
Which of the Blockbuster Drugs on the Autoimmune Drug Market Will Show the Glory that Humira Had?(1)
Siyi
June 05, 2018
The market performance of the autoimmune drug market has been mounting and rapidly growing in recent years